AllCells products

AllCells’ GMP Mobilized leukopaks are apheresis products collected from healthy donors treated with FDA-approved drugs to stimulate mobilization of CD34+ hematopoietic stem and progenitor cells from the bone marrow to the peripheral blood. This procedure results in large-scale yields of CD34+ cells. Peripheral blood is collected from IRB-consented donors using the continuous flow Spectra Optia^® Apheresis System directly into ACD-A anticoagulant at AllCells’ FDA-registered, IRB-approved collection facilities. Regimen details: Reg H = Filgrastim (Neupogen^®) 10ug/kg/day x 5 days + Plerixafor (Mozobil^®) 240ug/kg/day x 2 days on day 4 and 5 (evenings), apheresis on day 5 and 6.

AllCells’ GMP Fresh Leukopak products are collected by apheresis from peripheral blood of healthy donors. Our Leukopaks contain a high concentration of lymphocyte populations, T Cells, B Cells, NK Cells, and monocytes. AllCells maintains on-site, FDA-registered donor centers for the collection of all products from IRB-consented healthy donors providing customers with a streamlined process for procuring clinical grade primary cells. A Certificate of Analysis (CoA) and summary of record are provided with every order. Clinical Grade Fresh Leukopaks are only available through consultation with an AllCells Made-to-Order representative. Diverse Donor Pool and Extensive Donor Screening, High viability and stability leukopaks, GMP qualification of SOPs and stringent quality systems, Integrated Project Management approach to meet your specific criteria